Mark Howard Snyder - SVP, CHIEF LEGAL OFFICER at Halozyme Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Svp, Chief Legal Officer
Stock Symbol
HALO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Howard Snyder since 4/23/2024

Holdings reported by Mark Howard Snyder for Halozyme Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 28.5K $1.65M $57.75 Feb 23, 2025 Direct
Restricted Stock Units 21K $1.21M $57.75 Feb 23, 2025 Direct Common Stock
Performance Stock Unit 7.27K $410K $56.41 Feb 12, 2025 Direct Common Stock
Option to Purchase Common Stock 29.1K $403K $13.87 Feb 23, 2024 Direct Common Stock
Option to Purchase Common Stock 22.6K $314K $13.87 Feb 20, 2025 Direct Common Stock
Performance Stock Units 0 $0 $58.29 Feb 16, 2025 Direct Common Stock

Transactions reported by Mark Howard Snyder for Halozyme Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.